City

Hangzhou (1)

Napoli (1)

Condition

ADCC (2)

Adaptive Transfer (1)

Advanced Cancer (1)

Colorectal Cancer (1)

NK Cell Mediated Immunity (1)

Nimotuzumab (1)

Overall Status

Recruiting (1)

Unknown status (1)

Sign in for free

Phase

phase 1 (1)

phase 2 (1)

Sponsor

Hangzhou Cancer Hospital (1)

National Cancer Institute, Naples (1)

Collaborator

Shanghai bokang bioengineering co., LTD (1)

Intervention

folfiri/cetuximab (1)

nimotuzumab (1)

nk cell adaptive transfer (1)

Study Documents

Intervention Type

drug (2)

biological (1)

Funder Type

Other (2)

Study Type

Interventional (2)

adcc

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Colorectal Cancer, ADCC Trial in Napoli (Folfiri/Cetuximab)

Recruiting

Colorectal Cancer
ADCC

Folfiri/Cetuximab

Napoli, Italy

Istituto Nazionale dei Tumori,

Sep 1, 2021

Advanced Cancer, ADCC, NK Cell Mediated Immunity Trial in Hangzhou (NK Cell adaptive transfer, Nimotuzumab)

Unknown status

Advanced Cancer
+4 more

NK Cell adaptive transfer
Nimotuzumab

Hangzhou, Zhejiang, China

Hangzhou Cancer Hospital

Jun 12, 2018